Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study

J. Wolf, T. Overbeck, J. -Y. Han, M. Hochmair, F. De Marinis, K. Ohashi, E. F. Smit, D. Power, E. B. Garon, H. J. M. Groen, D. S. W. Tan, M. Waldron-Lynch, S. Le Mouhaer, N. Nwana, M. Giovannini, R. S. Heist

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)150-151
Number of pages2
JournalOncology Research and Treatment
Issue numberSUPPL 4
Publication statusPublished - Oct-2020

Cite this